Patent

BioArctic is Granted a Concept Patent in Europe for the Company's Strategy for Disease-modifying Treatment of Parkinson's Disease

Retrieved on: 
Sunday, October 21, 2018
Patent law, Biosimilar, Biotechnology, Drugs, Patent, Nature, Biology

The granted concept patent in Europe protects the company's innovative treatment strategy for Parkinson's disease.

Key Points: 
  • The granted concept patent in Europe protects the company's innovative treatment strategy for Parkinson's disease.
  • BioArctic's patent strategy is to protect our treatment strategy conceptually, with broad claims that prevent competitors from using the same treatment strategy, complemented by specific substance patents to provide protection against generics and biosimilars.
  • The company has an active patent strategy covering all major geographic markets, including the US, Japan, China and Europe.
  • "The granted concept patent in Europe, which protects the company's innovative treatment strategy for Parkinson's disease, is an in important part of the company's patent strategy.

Irras Expands its Management Group

Retrieved on: 
Friday, October 19, 2018
Monopoly, Patent, NASDAQ, Corporate finance, Finance, Economy of the United States

IRRAS AB (Nasdaq First North Premier: IRRAS) is a publicly-traded, commercial-stage medical technology company focused on developing and commercializing innovative solutions for brain surgery.

Key Points: 
  • IRRAS AB (Nasdaq First North Premier: IRRAS) is a publicly-traded, commercial-stage medical technology company focused on developing and commercializing innovative solutions for brain surgery.
  • With its unique product portfolio, protected by property patents and patent applications, IRRAS is well positioned to establish a leadership position in the medical device market.
  • IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in Munich, Germany, and San Diego, California, USA.
  • This document is considered information that IRRAS is obliged to disclose pursuant to the EU Market Abuse Regulation.

Irras Expands its Management Group

Retrieved on: 
Friday, October 19, 2018
Monopoly, Patent, NASDAQ, Corporate finance, Finance, Economy of the United States

IRRAS AB (Nasdaq First North Premier: IRRAS) is a publicly-traded, commercial-stage medical technology company focused on developing and commercializing innovative solutions for brain surgery.

Key Points: 
  • IRRAS AB (Nasdaq First North Premier: IRRAS) is a publicly-traded, commercial-stage medical technology company focused on developing and commercializing innovative solutions for brain surgery.
  • With its unique product portfolio, protected by property patents and patent applications, IRRAS is well positioned to establish a leadership position in the medical device market.
  • IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in Munich, Germany, and San Diego, California, USA.
  • This document is considered information that IRRAS is obliged to disclose pursuant to the EU Market Abuse Regulation.

InventHelp Inventor Develops ROOM FINDER (BMA-5229)

Retrieved on: 
Wednesday, October 17, 2018
Finder, Patent

PITTSBURGH, Oct. 17, 2018 /PRNewswire/ --"I wanted to create a way to help my son safely navigate through school hallways," said an inventor, from Lowell, Mass., "so I invented the ROOM FINDER."

Key Points: 
  • PITTSBURGH, Oct. 17, 2018 /PRNewswire/ --"I wanted to create a way to help my son safely navigate through school hallways," said an inventor, from Lowell, Mass., "so I invented the ROOM FINDER."
  • The patent pending ROOM FINDER provides an effective way to help students find their classrooms.
  • As a result, it could encourage independence and it provides added comfort and peace of mind.
  • Additionally, the ROOM FINDER is producible in design variations.

InventHelp Inventors Design Upgrade Pacifier (AAT-4120)

Retrieved on: 
Tuesday, October 16, 2018
Human behavior, Infancy, Patent law, Creativity, Invention, Caregiver, Inventor, Pacifier, Patent

The patent pending JAMESON is a new, inventive and updated pacifier that is practical and convenient in nature.

Key Points: 
  • The patent pending JAMESON is a new, inventive and updated pacifier that is practical and convenient in nature.
  • It soothes and comforts babies, as well as promotes peace of mind for the parent or caregiver.
  • "I came up with this idea as I can never find my son's pacifier when needed, and I keep having to buy more," said the inventor.
  • The original design was submitted to the Atlanta office of InventHelp.

Lockpath Receives Multiple United States Patents

Retrieved on: 
Tuesday, October 16, 2018
LockPath, Patent

OVERLAND PARK, Kan., Oct.16,2018 /PRNewswire/ -- Lockpath , a leading provider of integrated risk management solutions, today announced the receipt of two newly issued patents related to its Keylight Platform .

Key Points: 
  • OVERLAND PARK, Kan., Oct.16,2018 /PRNewswire/ -- Lockpath , a leading provider of integrated risk management solutions, today announced the receipt of two newly issued patents related to its Keylight Platform .
  • On September 25, the United States Patent and Trademark Office issued Lockpath U.S. Patent number 10,083,016 entitled "Procedurally Specifying Calculated Database Fields and Populating Them".
  • Together, the new patents reinforce Lockpath's position as an innovator and leader in the GRC and integrated risk management space.
  • Follow Lockpath on LinkedIn and on Twitter at @Lockpath and @KeylightGRC for the latest in industry, company and product news.

The HydraFacial® Company Partners With Circadia

Retrieved on: 
Monday, October 15, 2018
Monopoly, Patent

"We are thrilled to expand our portfolio of customized treatment solutions, integrating these exceptional Circadia formulas with the HydraFacial technology" states Clint Carnell, Chief Executive Officer of The HydraFacial Company.

Key Points: 
  • "We are thrilled to expand our portfolio of customized treatment solutions, integrating these exceptional Circadia formulas with the HydraFacial technology" states Clint Carnell, Chief Executive Officer of The HydraFacial Company.
  • HydraFacial is an innovative skin-health company with 30 patents, and 24 patents pending.
  • "Circadia is proud to utilize our innovative skin science and formulary expertise to deliver these exclusive boosters through the HydraFacial patented technology for exceptional results," said Michael Q. Pugliese, CEO of Circadia.
  • The company pioneered hydradermabrasion and now HydraFacial and Perk products are popular in over 87 countries around the world.

Symfact adds Intellectual Property Management to its software suite

Retrieved on: 
Monday, October 15, 2018
Intangible assets, Intellectual property law, Monopoly, Intellectual property, Social information processing, Patent portfolio, Trademark, Patent, Human behavior, Arts, Creativity, LexInnova Technologies

The additional software extends this solution portfolio with:

Key Points: 
  • The additional software extends this solution portfolio with:
    Symfact Intellectual Property Management is a solution that manages Intellectual Property Rights such as patents, trademarks, logos, designs, domain names etc.
  • Enabling visibility into this critical information, Symfact provides the perfect foundation for systematic, procedure based patent management.
  • Symfact is an international company with an industry leading software portal for enterprise management solutions.
  • We focus to provide a single software platform to address the multiple domains of Contract and Compliance Management.

Metrasens Acquires New Patents to Further Protect Its Innovative Technology

Retrieved on: 
Thursday, October 11, 2018
Monopoly, Patent, Magnetic resonance imaging, Innovation, Human behavior, Economy, Science and technology

The recently granted patents (US 9514624 and EP2606387, US9995713 and EP2725973) cover features designed to optimize usability in MRI safety applications, and the use of a separate pre-screening device, which is also at the heart of Metrasens security systems.

Key Points: 
  • The recently granted patents (US 9514624 and EP2606387, US9995713 and EP2725973) cover features designed to optimize usability in MRI safety applications, and the use of a separate pre-screening device, which is also at the heart of Metrasens security systems.
  • These patents add to Metrasens' growing reputation for innovation directed at helping to make the world a safer place.
  • The company was recently awarded the Queen's Award for Enterprise, the UK's most prestigious business award, in the category of Innovation.
  • "As an innovative technology company our intellectual property is very important to us.

BRG Professionals Recognized as Leading IP Patent and Strategy Experts in IAM 2018 Guides

Retrieved on: 
Wednesday, October 10, 2018
Monopoly, Patent law, Patent, Law, Practice of law, Outline of patents

Managing Directors William Kerr and Catharine Lawton were named among the IAM Patent 1000 - The World's Leading Patent Professionals .

Key Points: 
  • Managing Directors William Kerr and Catharine Lawton were named among the IAM Patent 1000 - The World's Leading Patent Professionals .
  • This guide identifies and profiles leading private practice patent professionals and firms in the world's key jurisdictions, as well as expert witnesses in the United States.
  • Managing Director David Kennedy and Director Larry Rosenberg were named among the IAM Strategy 300 - The World's Leading IP Strategists .
  • He structured numerous investments in patent portfolios and patent monetization programs, and has negotiated the business terms of patent licenses and settlements of patent litigation.